Basket | Login


P20. Diagnosis of dementia: an interactive and educational session

Detailed programme and abstracts

van der FLIER Wiesje, van GILS Mark, HASSELBALCH Steen, BRUUN Marie, SOININEN Hilkka, RHODIUS - MEESTER Hanneke, LÖTJÖNEN Jyrki

Dementia diagnosis can be a challenge for clinicians. Early and accurate diagnosis is essential for adequate treatment and care, but daily clinical practice is complicated. During the diagnostic work-up of dementia, many different types of data are collected. To combine, weigh and translate these results to clinical practice is not straightforward.

The aim of this PredictND symposium is to provide insight in some of the most important aspects of dementia diagnosis. In a series of interactive sessions, we will provide a comprehensive overview of hallmarks and pitfalls in diagnosis of dementia and translation to clinical practice.

We start with a short introduction to the European PredictND project that aims to develop computer tools to aid in differential diagnosis of neurodegenerative diseases. Next, we provide a description of the characteristics of different types of dementia and highlight challenges for the clinician. We continue with a hands-on introduction to several neuropsychological tests and to visual rating of brain MRI with a focus on memory clinic decision making. After that we outline different approaches that could be used in the future to detect cognitive disorders earlier with a focus on primary care. We will then move to an innovative field in diagnosis of dementia, the use of computer tools to assist clinician, in a truly interactive session where we will discuss difficult cases to evaluate and whether the PredictND tool has added value. We will finish the symposium with an overview of the key outcomes of the PredictND project.

The session Diagnosis of dementia is organised by the PredictND consortium.



Last Updated: Monday 23 October 2017


  • Acknowledgements

    The 27th AE Conference in Berlin received funding under an operating grant from the European Union’s Health Programme (2014-2020). Alzheimer Europe and Deutsche Alzheimer Gesellschaft e.V. gratefully acknowledge the support of all conference sponsors.
  • European Union
  • Roche